Amedisys (AMED) Tops Q4 EPS by 1c, Revs Miss
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/22/2026
- Wall St indexes advance with boost from chips, Iran optimism
- Intel soars after Trump says Apple agreed to work with chipmaker on US production
- Apple CEO warns price hikes 'unavoidable' as chip costs bite - WSJ
- Wall Street scrambles to lift Micron price targets ahead of earnings
- SanDisk and Micron surge as Apple confirms memory price pass-through
- Zelenskiy: best guarantee of Europe's future is fast-track EU membership for Ukraine
- Needham Starts NeoVolta (NEOV) at Buy
- CoreWeave trains DeepSeek-V3 in two minutes in MLPerf benchmark
- Companies to add 40 million barrels of oil to US SPR after Iran war ends, energy secretary says
- China makes small dent in deflation battle as supply-demand imbalance persists
Amedisys Reports Fourth Quarter and Year End 2019 Financial Results and Issues 2020 Guidance
February 18, 2020 4:15 PM ESTBATON ROUGE, La., Feb. 18, 2020 (GLOBE NEWSWIRE) -- Amedisys, Inc. (NASDAQ: AMED) today reported its financial results for the three month period and year ended December 31, 2019.
Three Month Periods Ended December 31, 2019 and 2018
Net service revenue increased $66.3Â million to $500.7Â million compared to $434.4Â million in 2018.Net income attributable to Amedisys, Inc. of $27.7Â million compared to $27.5Â million in 2018.Net income attributable to Amedisys, Inc. per diluted share of $0.83 compared to $0.84 in 2018.Adjusted Quarterly Results*
Adjusted EBITDA of $52.2Â million compared to $43.9Â million in 2018.Adjusted net service revenue of $500.7Â million compared to $434.4Â million in... More